.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Accenture
Cipla
Daiichi Sankyo
Dow
Harvard Business School
Queensland Health
Citi
McKesson
Chubb

Generated: December 14, 2017

DrugPatentWatch Database Preview

Colestipol hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for colestipol hydrochloride and what is the scope of colestipol hydrochloride patent protection?

Colestipol hydrochloride
is the generic ingredient in three branded drugs marketed by Pharmacia And Upjohn and Impax Labs, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for colestipol hydrochloride. Six suppliers are listed for this compound.

Pharmacology for colestipol hydrochloride

Medical Subject Heading (MeSH) Categories for colestipol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Impax LabsCOLESTIPOL HYDROCHLORIDEcolestipol hydrochlorideGRANULE;ORAL077277-001May 2, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Impax LabsCOLESTIPOL HYDROCHLORIDEcolestipol hydrochlorideGRANULE;ORAL077277-002May 2, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Impax LabsCOLESTIPOL HYDROCHLORIDEcolestipol hydrochlorideTABLET;ORAL077510-001Oct 24, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Pharmacia And UpjohnCOLESTIDcolestipol hydrochlorideTABLET;ORAL020222-001Jul 19, 1994ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Pharmacia And UpjohnFLAVORED COLESTIDcolestipol hydrochlorideGRANULE;ORAL017563-001Approved Prior to Jan 1, 1982RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Pharmacia And UpjohnFLAVORED COLESTIDcolestipol hydrochlorideGRANULE;ORAL017563-002Approved Prior to Jan 1, 1982RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Pharmacia And UpjohnCOLESTIDcolestipol hydrochlorideGRANULE;ORAL017563-004Sep 22, 1995ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Pharmacia And UpjohnCOLESTIDcolestipol hydrochlorideGRANULE;ORAL017563-003Sep 22, 1995ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: colestipol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And UpjohnFLAVORED COLESTIDcolestipol hydrochlorideGRANULE;ORAL017563-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pharmacia And UpjohnCOLESTIDcolestipol hydrochlorideTABLET;ORAL020222-001Jul 19, 1994► Subscribe► Subscribe
Pharmacia And UpjohnFLAVORED COLESTIDcolestipol hydrochlorideGRANULE;ORAL017563-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Fish and Richardson
US Army
Merck
Cipla
Healthtrust
Boehringer Ingelheim
Novartis
Cantor Fitzgerald
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot